A Right Intercosto-Bronchial Artery Derived from the Thyrocervical Trunk: An Unusual Cause of Type II Endoleak Post Thoracic Aortic Stenting.

The aetiology, incidence and management of type II endoleaks in standard infrarenal endovascular aortic aneurysm repair is well described. Far less data is available for thoracic stent grafting. We present a rare and interesting case of a type II endoleak post thoracic aortic stenting and highlight the aberrant anatomy that can cause this phenomenon in such cases.

CASE REPORT

A 79-year-old woman presented to our tertiary referral vascular surgical centre with an incidental finding of a thoracic aortic aneurysm on routine chest radiography. Upon further investigation, she was found to have an isolated descending thoracic aortic aneurysm secondary to a previous open aortic coarctation repair that she had undergone at the age of 38. She underwent a left carotid-subclavian bypass graft with left vertebral reimplantation prior to the completion of thoracic aortic stent grafting nine days later. An angiogram taken after thoracic aortic stent grafting and a post-implantation computed tomography angiogram performed the following day demonstrated no endoleak, and she was discharged eight days later.

Four months later, a small type II endoleak was subsequently demonstrated with minimal expansion of the aneurysm sac. Over the course of the following five years, she underwent regular observation until sac expansion required further investigation and intervention. Catheter-directed angiography demonstrated that the right intercostal bronchial artery was communicating with the aneurysm sac, corresponding to the type II endoleak seen on computed tomography angiography (Fig. 1). Onyx (Covidien, Irvine, CA, USA) was used to perform standard coil embolization, and no flow into the aneurysm sac was found after the procedure (Fig. 2).

Fig. 1

Right Intercosto-bronchial Artery Derived from the Thyrocervical Trunk Post Thoracic Aortic Stenting Causing a Type II Endoleak.

Fig. 2

Endoleak Resolution Following Onyx and Coil Embolisation.

DISCUSSION

Whilst the phenomenon of type II endoleaks and their management is well described for the endovascular repair of infrarenal aneurysms, there is less data available about type II endoleaks following thoracic aortic stent grafting. The incidence of type II endoleaks following thoracic aortic stenting can be as high as 10.6% [1]. To our knowledge, only one similar report of a thyrocervical derived collateral causing a type II endoleak exists, described by Rivera-Sanfeliz et al. [2]. They describe a right thyrocervical trunk bronchial collateral, which is very similar to our description of an endoleak occurring in the intercostal bronchial artery. We strongly agree with their statement that the “examination of potential anomalous or collateral thoracic pathways is mandatory when considering treatment of a type II endoleak following endovascular TAA repair.”

“Onyx is a non-adhesive liquid embolic agent used for the pre-surgical embolization of brain arteriovenous malformations and aneurysms. Onyx is comprised of an ethylene vinyl alcohol copolymer dissolved in dimethyl sulfoxide, with suspended micronized tantalum powder to provide contrast for visualization under fluoroscopy [3].” The use of Onyx to treat type II endoleaks in endovascular abdominal aortic aneurysm repair was first reported in 2001 [4]. It is now a well-described and frequently used technique in the management of type II endoleaks following the endovascular repair of both abdominal and thoracic aneurysms [5-8]. However, its use for this purpose remains unlicensed and off-label. Our case further demonstrates the usefulness of Onyx for type II endoleak embolization following endovascular aneurysm repair, even in unusual cases involving aberrant anatomy.